<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04051983</url>
  </required_header>
  <id_info>
    <org_study_id>S61226</org_study_id>
    <nct_id>NCT04051983</nct_id>
  </id_info>
  <brief_title>iVision - Development of a Game-based Therapy for Children With Cerebral Visual Impairment</brief_title>
  <acronym>iVision</acronym>
  <official_title>iVision - Development of a Game-based Therapy for Children With Cerebral Visual Impairment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitaire Ziekenhuizen Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Research Foundation Flanders</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>KU Leuven</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Free University of Brussels</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Ghent</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ganspoel</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universitaire Ziekenhuizen Leuven</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the present study is to develop a therapeutic, adaptive, and enjoyable game
      that will be used by children with CVI between the mental age of 3 and 12 years. Such a game
      will be easy to use and implement by the children, their parents, and therapists.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this project is to develop a novel and adaptive gamified visual perceptual therapy
      platform for children with cerebral visual impairment.

      This is a multi-centered study involving multiple partners, namely KU Leuven, VUB, UGent, and
      a subcontracted game developer. Children and parents will take part during different phases
      of the research project as described in detail in the different phases below.

      Phase I: Quantification of the visual profile (WP1) A quantification of the visual profile of
      children with CVI will be made by KU Leuven. This will be done using the results conducted at
      consultations at the CVI clinic at the Centre For Developmental Disabilities Leuven, Centrum
      Ganspoel, and the CP Reference Centre. A group of 50 children with CVI will be
      retrospectively recruited and results from their perceptual tests will be used to quantify
      their visual profile.

      Phase II: Definition of user and technical requirements (WP1). A definition of user
      requirements for the development of the software and mini-games will be identified based on
      at least two focus groups involving parents and therapists. Two focus groups with
      parents/caretakes and therapists (one for each age group of the children) each lasting
      maximum three hours with a limit of 10 participants.

      There is also a step involving the technical foundations and development of building blocks,
      but this will not involve patients, therefore it is not discussed further (WP2).

      Phase III: Development and validation of the Relative Enjoyment Scale for Primary School
      Children (RES-C;WP1). The development and validation of the Relative Enjoyment Scale for
      Primary School Children (RES-C) instrument will be developed considering not just the
      affective and the cognitive dimensions of RES-C, but also its socio-cultural embeddedness, by
      measuring the child's experience in relation to what they have encountered before their
      experience horizon. The questionnaire will be developed by structured individual interviews
      with 20 children (10 from each age group).

      Phase IV: Initial prototype testing (WP3). During prototype development a game design
      document will be created, specifying what the core gameplay mechanics are, how the game will
      look in terms of art and customizable visuals/gameplay. VUB will use the coded visual
      perceptual profile of the children and map these profiles onto the appropriate game
      difficulty levels for each child. Prototype testing will occur using structured interviews
      with 20 children (10 from each age group) while they play the game.

      The present study will end in October 2020. Phase I, Phase II, and Phase III will be
      completed by October 2019. Phase IV will be completed by October 2020.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 2, 2018</start_date>
  <completion_date type="Anticipated">October 2020</completion_date>
  <primary_completion_date type="Anticipated">October 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <target_duration>2 Years</target_duration>
  <primary_outcome>
    <measure>L94 Visual Perceptual Battery</measure>
    <time_frame>60 minutes</time_frame>
    <description>L94 is an object recognition battery for children aged 3-6 years. The test is composed of 5 computer tasks, [visual matching (VISM), overlapping line drawings (OVERL), line drawings occluded by noise (NOISE), De Vos task (DE VOS), unconventional object views (VIEW). (Ortibus et al., 2009)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Test of Visual Perceptual Skills (TVPS)</measure>
    <time_frame>45 minutes</time_frame>
    <description>TVPS-3 is a standardized and norm-referenced task for children age 4-13 years that uses a response format suitable for all children, including those with disabilities. It includes subtasks of visual discrimination, visual memory, visual-spatial relationships, form constancy, visual sequential memory, figure ground, and visual closure (Martin et al., 2006).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Developmental Test of Visual - Motor Integration (Beery VMI)</measure>
    <time_frame>20 minutes</time_frame>
    <description>Beery a standardized and norm-referenced screening tool for visual-motor deficits. It includes updated norms for ages 2 through 18. The VMI helps assess to what extent children can integrate their visual and motor abilities. In addition to a copying task, the child also performs a visual perception matching task of the same constructs seen before in the copy task, and a motor coordination task, developed to assess the supplementary motor deficits. (Beery et al., 2010).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Developmental Neuropsychological Assessment (NEPSY-II-NL)</measure>
    <time_frame>Subtests geometric puzzles and arrows, 20 minutes</time_frame>
    <description>NEPSY-II-NL is a customizable cognitive assessment tool for children aged 5 to 16 years. It assesses six domains with one integrated instrument, composed of different normed subtests. Among those, visual attention and visuospatial functions, are routinely performed in the diagnostic work up of children with (a suspicion of) CVI. (Korkman, 1998).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Revisie Amsterdamse Kinderintelligentie Test (RAKIT)</measure>
    <time_frame>Subtests Hidden figures and Recognize figures, 20 minutes</time_frame>
    <description>RAKIT is a paediatric intelligence test, with reference values from a Dutch population of children 4-12.5 years of age. From this test, the subtest &quot;Vertelplaat&quot; is used to evaluate the ability to tell a logic story from a crowded scene, thereby evaluating object recognition, figure ground perception and scene perception (Bleichroth et al., 1987).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Relative Enjoyment Scale for Primary School Children (RES-C)</measure>
    <time_frame>10 minutes</time_frame>
    <description>The RES-C measures enjoyment by relating it subjectively to a series of other activities which are part of the 'experience horizon' of a child using visual analogue scales (Van Looy et al., 2016)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Snijders-Oomen Non-verbal intelligence test (SON-R 6-40)</measure>
    <time_frame>60 minutes</time_frame>
    <description>The SON-R 6-40 consists of four subtests containing two or three parallel series of twelve to thirteen items with increasing difficulty. The testing procedure of this test is adaptive, whereby the starting point of a series is decided on basis of the score on the previous series of the subtest.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Wechsler Preschool and Primary Scale of Intelligence (WPPSI-III-NL)</measure>
    <time_frame>Non-verbal subtests, 60 minutes</time_frame>
    <description>Third Edition (WPPSI-III) is designed to test intelligence (cognitive ability) in children ages 2 years 6 months to 7 years 3 months. The test consists of 14 subtests from which five subtests measure the non-verbal intelligence.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Visual Perceptual Weakness (Disorder)</condition>
  <condition>Cerebral Visual Impairment</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Fifty children will be recruited from the consultations at the CVI clinic at the Centre For
        Developmental Disabilities Leuven, from Centrum Ganspoel, and the CP reference Centre of
        the UZ Leuven.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Visual perceptual deficits or diagnosed with CVI

          -  Gross Motor Function Classification (GMFCS) level I-IV

          -  Two age groups; 3-7 and 8-12 years of mental age

        Exclusion Criteria:

          -  mental age below 3 and above 12 years of mental age

          -  severely limited motor abilities (cerebral palsy with a gross motor function
             classification level V)

          -  severely limited or unable to express their experiences with the game due to serious
             speech disorders, deafness, autism

          -  visual acuity of â‰¤ 3/10
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Els Ortibus, Professor</last_name>
    <role>Study Director</role>
    <affiliation>UZ Leuven</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nofar Ben Itzhak, Master</last_name>
    <phone>016 33 75 08</phone>
    <email>nofar.benitzhak@kuleuven.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Inge Franki, PhD</last_name>
    <phone>016 33 74 95</phone>
    <email>inge.franki@uzleuven.be</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>UZ Leuven</name>
      <address>
        <city>Leuven</city>
        <state>Vlaams-brabant</state>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nofar Ben Itzhak, Master</last_name>
      <email>nofar.benitzhak@kuleuven.be</email>
    </contact>
    <contact_backup>
      <last_name>Inge Franki, PhD</last_name>
      <phone>016337495</phone>
      <phone_ext>016337495</phone_ext>
      <email>inge.franki@uzleuven.be</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>August 7, 2019</study_first_submitted>
  <study_first_submitted_qc>August 8, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 9, 2019</study_first_posted>
  <last_update_submitted>August 8, 2019</last_update_submitted>
  <last_update_submitted_qc>August 8, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 9, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vision Disorders</mesh_term>
    <mesh_term>Vision, Low</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

